Researchers looking for root causes of long COVID work in the autopsy suite inside the Clinical Center at the National Institute of Health in Bethesda, Maryland.
(
Valerie Plesch
/
Bloomberg via Getty Images
)
Topline:
There's still no validated treatment or diagnostic test specifically for long COVID's often disabling symptoms — although there are many candidates.
Why it matters: Clinicians who treat long COVID are acutely aware of the unsettled nature of the field. "You do sort of feel like you're out in the wilderness," says Dr. Rasika Karnik, medical director of UChicago Medicine's post-COVID clinic.
What we do know: If long COVID were a crime scene, authorities would have no shortage of leads. They've pinpointed a handful of possible reasons why patients suffer from an array of chronic symptoms. The tricky thing is disentangling which mechanisms are bystanders and which are actually doing the damage.
For people suffering from long COVID's often disabling symptoms, including intense fatigue, breathing troubles, cognitive issues and heart palpitations, the list of scientific unknowns may sound defeating. There's still no validated treatment or diagnostic test specifically for the condition, although there are many candidates.
Clinicians who treat long COVID are acutely aware of the unsettled nature of the field. "You do sort of feel like you're out in the wilderness," says Dr. Rasika Karnik, medical director of UChicago Medicine's post-COVID clinic.
Karnik first began seeing long COVID patients in the fall of 2020. There's more information to work with now, she says, but doctors' approach still comes down to treating individual symptoms, rather than the underlying cause of the illness. "It's hard to look a patient in the eyes and say 'we're not quite sure yet' and to keep repeating that," she says.
But researchers are making progress in the field, and they presented their recent findings at one of the first major gatherings dedicated to sharing emerging evidence about the possible root cause of long COVID and implications for treatment.
"I know there's been a lot of frustration that there haven't been faster answers," says Dr. Catherine Blish, a professor of medicine at Stanford University and one of the organizers of the conference, held by the nonprofit Keystone Symposia in Santa Fe, N.M., in late August.
"But in all honesty, we are so much further ahead at this relative point than for any other major disease in my lifetime as an infectious disease specialist," she says.
The meeting underscored that scientists have made headway in developing evidence of a clear biological basis for what patients have been reporting for years.
"I've never doubted it — people are suffering," says Harlan Krumholz, a cardiologist at Yale University who's involved in long COVID research. "But we're now seeing imaging evidence, biopsy evidence, physiologic testing evidence of derangements in people who have long COVID."
Here are some of the new findings and promising lines of research highlighted during the three-day gathering.
Narrowing in on some key suspects behind the disease
If long COVID were a crime scene, authorities would have no shortage of leads.
They've pinpointed a handful of possible reasons why patients suffer from an array of chronic symptoms. The tricky thing is disentangling which mechanisms are bystanders and which are actually doing the damage.
"At this point, we have hints and correlative data," says Blish. "We can say we see this finding in a subset of people, but that doesn't mean it's the cause of their problems."
Take the theory of viral persistence: There's now strong evidence that protein and genetic material from SARS-CoV-2 persist in the blood and tissue of some long COVID patients well after their initial illness. Scientists believe these "viral reservoirs" could be driving many of the problems in long COVID patients, although it isn't yet clear exactly how this is happening — and whether the virus itself is replicating.
Dr. Michael Peluso, an infectious disease specialist at the University of California, San Francisco, told conference attendees that his team is now confident in their data showing pieces of viral antigen in the blood of people anywhere from six months to more than a year after they've had COVID-19.
They compared these blood samples to ones collected years before the pandemic to verify their conclusions. "That's a very, very important finding, showing that this is indeed real," he says.
But the story gets more messy from there because these viral reservoirs may not be the primary culprit.
While they are more likely to find viral persistence in the most symptomatic long COVID patients, not everyone with long COVID has it, Peluso notes, "And then really importantly, we're also seeing this in some people who feel totally fine — and we don't know what that means."
Finding activated T cells where they shouldn't be
Other leads have come from imaging technology that traces the activity of T cells, a type of white blood cell, which are part of the body's main antiviral immune response.
"We saw some very unexpected findings," says Dr. Timothy Henrich, an associate professor of medicine at the University of California, San Francisco.
His lab has found activated T cells in the gut wall, lung tissue, certain lymph nodes, the bone marrow, the spinal cord and the brainstem, long after someone's initial infection.
"You really shouldn't have activated T cells in the spinal cord or the brainstem," he says. "We are seeing evidence of this immune response in areas we don't typically see in the setting of an acute viral infection."
Here too the immunological detective work opens up even more questions: This T cell activity is also present in people who've recovered from an infection and have no long COVID symptoms, although Henrich notes the levels appear to be higher in certain tissues of people with long COVID.
So what does this immune response actually indicate about the underlying cause of the disease?
Henrich says T cell activity could be evidence that the immune system is trying to purge the viral reservoirs, or that the immune response has gone awry, possibly in the form of an autoimmune response, and is "doing damage to people, even if the virus has been cleared or is not replicating in those tissues," he says.
Patients and advocates for people suffering from long COVID and myalgic encephalomyelitis/chronic fatigue syndrome hosted an installation of 300 cots in front of the Washington Monument on the National Mall in Washington, D.C., in May, to represent the millions of people suffering from post-infectious disease.
(
Andrew Harnik
/
AP
)
Similar questions bedevil researchers pursuing another theory.
Akiko Iwasaki, a professor of immunobiology at Yale University, says it's well known that this herpesvirus can lead to a "long COVID-like syndrome," but whether or not the reactivation is driving long COVID symptoms — or just an indication of a dysregulated immune system — remains to be seen.
All of those involved in research stress that they don't expect just one answer to long COVID. It's likely that many of these theories about its underlying cause are interrelated. And certain mechanisms may only be causing symptoms in some patients and not others.
Microclots could point the way to treatment
Early in the pandemic, it was recognized that COVID-19 can wreak havoc on the vascular system, in particular causing inflammation and damage to the inner lining of blood vessels, known as endothelial cells.
Resia Pretorius, a medical researcher at Stellenbosch University in South Africa, says the clotting and hyperactivation of platelets in long COVID is essentially a "persistent continuation" of what happens during an acute infection within the blood vessels.
Her research has focused on the role of tiny, harmful blood clots she's seeing in the blood of long COVID patients that appear to have "trapped inflammatory molecules that you might expect inside the blood if you have inflamed [or] damaged endothelial layers."
"It's not unique to long COVID, but long COVID has so much more of these inflammatory molecules in circulation," says Pretorius. "And what makes it so interesting is that the spike protein drives these microclots to form."
As the clots accumulate, they may choke off blood flow, preventing oxygen from reaching tissue.
In Santa Fe, Pretorius shared preliminary data from her team showing that so-called "triple therapy" — a combination of three medications — targeting clotting and platelet hyperactivation could benefit some long COVID patients. The preprint showed that this regime resolved symptoms in the majority of the 91 patients who were followed, although the results are not yet peer-reviewed and the study was not a clinical trial.
The approach is not without risk; many patients reported bruising, some had nosebleeds and one reported a gastrointestinal bleed.
Pretorius says microclots are not necessarily the root cause of long COVID, though.
It could be that viral reservoirs are actually helping trigger this vascular mayhem in the first place. These microclots, if left untreated, could also tie into other problems seen in long COVID patients, perhaps leading some to develop autoimmunity, says Pretorius. "That is a problem to solve because we know autoimmune diseases are notorious for being so, so difficult to treat."
Sex differences may play a role in long COVID risk
In general, males tend to do worse during an acute bout of COVID-19, but studies show that long COVID appears to be more prevalent among females. Yale's Iwasaki says this is also the case for other "post-acute infection syndromes."
This background led Iwasaki's lab to look into sex differences in the immune profiles of long COVID patients, in hopes of finding another path to understanding what could be driving the illness. She says they've found that reactivation of Epstein-Barr virus and the activation of T cells are more prevalent among females, whereas males have different "immune signatures."
"We're already starting to see sex differences in long COVID symptoms, as well as potentially the autoimmunity more associated with female patients," she says. "This insight is critical going forward because now we can separate out long COVID into different clusters. And depending on the driver of the disease, we can start targeting it with proper medicine."
Iwasaki's lab has also zeroed in on the role of hormones.
At the conference, she shared evidence of reduced cortisol levels in long COVID patients and shared a separate, unpublished finding that female long COVID patients tend to have reduced testosterone levels and that males have reduced estradiol levels.
Those who had lower testosterone (compared to the controls who don't have long COVID symptoms) also have higher activation of T cells, whether they're males or females, says Julio Silva, a graduate student in Iwasaki's lab who presented the new findings on testosterone. And this was "associated with higher neurological symptoms and overall higher symptom burden," says Silva.
The impetus to look at testosterone was, in part, because of "anecdotes from trans individuals who were informing us that while on testosterone therapy, their symptoms had improved dramatically," says Silva. While the results are preliminary and need to be replicated, he says they at least raise the question "could hormonal therapy help?"
Taken together, Iwasaki says their data strongly suggest there could be problems in the area of the brain that's responsible for regulating these hormones.
Viral persistence offers one possible target for treating long COVID
In the absence of a clear roadmap for treating long COVID, doctors and patients have taken to trying all kinds of therapies — from antivirals to drugs approved for treating addiction.
"All of this research is so critical to understanding the underlying mechanisms of long COVID," says Lisa McCorkell, co-founder of the advocacy group Patient-Led Research Collaborative. "We need to pair that with focusing on clinical trials. We have enough evidence right now to at least try some things."
In Santa Fe, UCSF's Peluso outlined how his team had just launched a small trial using monoclonal antibodies to target the coronavirus spike protein in long COVID patients — one vehicle for testing whether viral persistence is the underlying cause of at least some patients' symptoms. Meanwhile, Iwasaki and Krumholz, both at Yale, have started a clinical trial testing whether a 15-day course of Paxlovid can help alleviate symptoms.
Stanford's Blish points out that as more clinical trials start up, their success will hinge on being deliberate about which patients should be enrolled, since long COVID is a catch-all term for what may be multiple different illnesses.
"We need to understand in detail who's most likely to benefit from those trials, because if we just take everyone, that trial will fail," she says.
Many other trials are in the works, too, but Dr. Jennifer Curtin says those will inevitably take time to produce evidence that trickles down to patient care.
"It's that tough sort of in-between status right now," says Curtin, co-founder of the telehealth clinic RTHM that treats long COVID and other overlapping conditions like myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS for short. "So what do you do for the people who are sick and suffering now until we get that data?"
Curtin, who has lived with ME/CFS herself, says their clinic's approach is to perform intensive workups, draw lots of blood and try to identify which symptoms they can treat.
"Treatment is very much individually tailored," she says. "Right now it's a journey that you take with your patients. You're going through this together. You're both learning on this road and it can be tough."
Always in the backdrop at the Santa Fe gathering was the question of whether there would be enough funding — be it from the U.S. Congress or the pharmaceutical industry — to advance the research agenda toward treatments.
"What we really need here is industry engagement. We need funding for clinical trials. And that, to me, is something that's missing," says McCorkell.
Destiny Torres
covers all things SoCal, from breaking news to local government, with a focus on Orange County.
Published November 16, 2026 4:19 PM
An Orange County Sheriffs deputy walks into the Intake and Release center at the the Orange County Central Men's Jail in Santa Ana.
(
Allen J. Schaben
/
Getty Images
)
Topline:
At least two employees of the OC Sheriff’s Department are on administrative leave as the department investigates a report that a deputy and sheriff’s special officer were seen communicating with ICE agents, according to OCSD.
What do we know: The department on Friday pointed to surveillance video from Oct. 31 was taken outside the Orange County Jail. It shows two OCSD employees “appearing to have a five-second conversation” with ICE agents in an unmarked vehicle parked outside the Orange County jail, according to the department. The conversation took place minutes before a man, who was hiding in the public courtyard, was arrested by the agents.
Background: State sanctuary law, known as the California Values Act, limits police cooperation with federal immigration agents and prohibits state and local law enforcement from investigating or arresting people for immigration enforcement purposes.
Read on… for how the Sheriff and OC officials are responding.
At least two employees of the Orange County Sheriff’s Department are on administrative leave as the department investigates a report that a deputy and sheriff’s special officer were seen communicating with ICE agents, according to OCSD.
The department on Friday pointed to surveillance video from Oct. 31 that was taken outside the Orange County Jail. It shows two OCSD employees “appearing to have a five-second conversation” with ICE agents in an unmarked vehicle parked outside the Orange County jail, according to the department. The conversation took place minutes before a man, who was hiding in the public courtyard, was arrested by the agents.
State sanctuary law, known as the California Values Act, limits police cooperation with federal immigration agents and prohibits state and local law enforcement from investigating or arresting people for immigration enforcement purposes.
Sheriff Don Barnes said in a statement that the department does not enforce federal immigration law but that he will fully cooperate with ICE to the extent the law allows.
“Personnel acting outside the law and department policy will be held appropriately accountable,” Barnes said.
He added the department will enforce state and local laws equally, without bias and without concern for anyone’s citizenship.
Carlos Perea, executive director of the Harbor Institute for Immigrant and Economic Justice, told LAist this incident shows OCSD’s culture.
“The department has expressed time and time again that they will work with ICE to the fullest extent of the law,” Perea said. “OC Sheriff Barnes should use this as a learning lesson to end all collaboration with ICE.”
Hector Bustos, communications director for political organizing group Chispa, told LAist he’s glad to see an investigation launched, but he’s not completely surprised by the incident.
“We have known for a very long time that the Orange County Sheriff's Department has had a very close relationship with ICE,” Bustos said. “Our hope is that there is an independent investigation here because we know that historically when law enforcement agencies are investigating themselves, we don't see accountability.”
OC Supervisor Vicente Sarmiento said he’s encouraged by the investigation, but that anxiety among residents is already heightened by the presence of ICE.
“What it does is it chills the average person from wanting to trust law enforcement when it comes to becoming a witness to a crime, or as a victim to a crime,” Sarmiento said. “The average person may not know state law and just believes that there is collaboration because you see many times federal agents calling local law enforcement for assistance.”
OC Supervisor Doug Chaffee, in a statement to LAist, welcomed the investigation and said any action that undermines trust or creates fear is concerning.
“Our local law enforcement agencies should not be participating in federal immigration enforcement,” Chaffee said. “Orange County must remain committed to protecting our residents, upholding California law, and ensuring that local law enforcement remains focused on public safety – not federal immigration enforcement.”
LAist is working to reach the family of the man who was arrested in the surveillance video.
Frank Stoltze
is a veteran reporter who covers local politics and examines how democracy is and, at times, is not working.
Published November 16, 2026 4:18 PM
An annotated image showing the various parts and instruments of NASA's Voyager space probe design. Voyager 1 and its identical sister craft Voyager 2 were launched in 1977 to study the outer Solar System and eventually interstellar space.
(
NASA/Getty Images
/
Hulton Archive
)
Topline:
NASA’s Voyager 1 spacecraft will reach one light day — or 16 billion miles — from Earth in interstellar space Wednesday, a distance reached by no other human-made object.
The details: One light day means it takes one day for a command sent by the Jet Propulsion Laboratory in Pasadena to reach Voyager 1.
The backstory: Voyager was launched in 1977 and is NASA’s farthest operating mission. It is also the longest-operating computer ever.
Still working: Voyager continues to beam back daily measurements regarding magnetic fields, plasma density and cosmic rays, using a couple of remaining operational instruments. Its cameras were turned off in 1990 to conserve energy. There’s not much to see in interstellar space. There’s very little light where Voyager is right now, according to project manager Suzanne Dodd.
How you can send a message to Voyager: After sunset on Tuesday, NASA invites you to join a worldwide celebration by creating a symbolic wave of golden light encircling Earth. NASA has created a website that enables smartphones and tablets to flash “VGR” — Voyager’s call sign — in Morse code. You can also just use a flashlight to flash the call sign to Voyager.
Keep up with LAist.
If you're enjoying this article, you'll love our daily newsletter, The LA Report. Each weekday, catch up on the 5 most pressing stories to start your morning in 3 minutes or less.
Elly Yu
reports on early childhood. From housing to health, she covers issues facing the youngest Angelenos and their families.
Published November 16, 2026 4:02 PM
LAUSD will survey parents, students and staff to help inform its policy about generative artificial intelligence.
(
Mel Melcon
/
Los Angeles Times via Getty Images
)
Topline:
The Los Angeles Unified School District wants to hear from community members about how to use generative artificial intelligence in schools. LAUSD is distributing a survey to help inform district policy.
The backstory: In September, LAUSD implemented a surprise moratorium on student use of generative AI on school-issued devices for this school year. Previously, district policy allowed students 13 and older to use the technology under supervision.
Why it matters: The school board has an ad-hoc committee on generative AI that examines the new technology and what its role should be in the classroom. The committee was formed as part of a resolution that was passed to limit screentime in the district.
What’s next: The ad hoc committee is scheduled to meet four more times this school year:
Dec. 9, 2026
Jan. 20, 2027
March 3, 2027
April 7, 2027
The committee plans to make policy recommendations that the full board could vote on.
A California Department of Corrections and Rehabilitation officer opens the gate for an incarcerated person leaving the exercise yard at San Quentin State Prison's death row in San Quentin on Aug. 15, 2016.
(
Justin Sullivan
/
Getty Images
)
Topline:
The district attorneys of 30 counties argued in a lawsuit filed Monday morning that the state’s high court should halt Gov. Gavin Newsom’s commutations of people on death row. The lawsuit, filed at the California Supreme Court, asserts that Newsom acted unlawfully when he proposed commuting the sentences of 548 prisoners by failing to afford the victims of their crimes the “opportunity to be heard.”
Why now: The petition distinguishes Newsom’s commutation powers from the pardon powers of a president — the presidential pardon doesn’t have any limits, other than impeachment. By contrast, when condemned California prisoners apply for a commutation, governors must notify the district attorney where the crime took place, and the victims or their families.
What's next: The California Supreme Court will get a say on almost 400 of Newsom’s commutations. State law requires the court to review those cases because the prisoners were convicted of multiple felonies. Representatives of the court have not said how or when those reviews would take place.
The district attorneys of 30 counties argued in a lawsuit filed Monday morning that the state’s high court should halt Gov. Gavin Newsom’s commutations of people on death row.
The lawsuit, filed at the California Supreme Court, asserts that Newsom acted unlawfully when he proposed commuting the sentences of 548 prisoners by failing to afford the victims of their crimes the “opportunity to be heard.”
“Only this court can stop the governor’s disregard of the law — his abuse of power,” the petitioners wrote to the California Supreme Court.
The petition distinguishes Newsom’s commutation powers from the pardon powers of a president — the presidential pardon doesn’t have any limits, other than impeachment. By contrast, when condemned California prisoners apply for a commutation, governors must notify the district attorney where the crime took place, and the victims or their families.
Perhaps anticipating this argument, Newsom issued an explanatory statement laying out why he didn’t need to issue notifications to victims or their families. A central factor was that none of these proposed commutations stemmed from an application from a prisoner on death row. By proposing a blanket commutation, Newsom asserted that none of the statutory requirements applied.
The section of the California penal code highlighted by the district attorneys “does not apply when the governor acts on his own initiative to grant clemency absent an application,” Newsom wrote in the explanation.
He added that, after he submitted the proposed commutations to the Supreme Court, his office would notify the district attorneys in the counties in which the crimes were committed and seek their help with notifications.
The California Supreme Court will get a say on almost 400 of Newsom’s commutations. State law requires the court to review those cases because the prisoners were convicted of multiple felonies. Representatives of the court have not said how or when those reviews would take place.
Newsom in 2019 issued a moratorium on executions and later ordered the dismantling of the death chamber at San Quentin State Prison. His successor, Gov.-elect Xavier Becerra, has committed to extending the moratorium when he takes office.